Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Curr Immunol Rev. 2010;6(1):38–55. doi: 10.2174/157339510790231833

Table 1.

Factors influencing fetal HSV or CMV infection

HSV CMV
Mechanical barriers Generally an ascending infection [42, 43]
Transit may be limited by anatomic barriers
(cervical plug; fetal membranes) and antimicrobial
peptides [41]
Generally a transplacental infection [55]
Site of latency Resides in neurons (dorsal root ganglia); may not
have access to uterine structures after reactivation
May reactivate from white blood cells in uterine
tissue [45]
Effect of maternal antibody More relevant to neonatal disease (discussed
below)
Neonatal Fc receptor may facilitate transplacental
transmission, especially in presence of low-avidity
maternal antibody [63]
Presence of viral receptors Not known to influence HSV infection of fetus Spatial regulation of putative CMV receptors may
influence infection [69]
Viral factors Latency is limited to neurons, which may
influence likelihood of transplacental spread
Infection may influence placental cell structure
and function [64].
HHS Vulnerability Disclosure